Showing results (91-100 of 228) with videos related to

Sort By:
Pageof 23
Blood Advances|January 14, 2025
Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCTShunto Kawamura, Daishi Nakagawa, Takashi Nagayama, et al.
Transplantation and Cellular Therapy|June 24, 2022
Low-Intensity Immunosuppressive Therapy for Chronic Graft-versus-Host DiseaseKazuki Yoshimura, Shun-Ichi Kimura, Hideki Nakasone, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2013
Allotype analysis to distinguish the origin of varicella-zoster virus immunoglobulin G after allogeneic stem cell transplantationRie Yamazaki, Hideki Nakasone, Yukie Tanaka, et al.
Journal of Clinical Immunology|July 6, 2012
Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantationYukie Tanaka, Hideki Nakasone, Rie Yamazaki, et al.
Scientific Reports|May 3, 2023
Impact of anti-thymocyte globulin on survival outcomes in female-to-male allogeneic hematopoietic stem cell transplantationMasaharu Tamaki, Yu Akahoshi, Masahiro Ashizawa, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 26, 2021
Association between the kinetics of cytomegalovirus reactivation in terms of the area under the curve of cytomegalovirus antigenemia and non-relapse mortality after allogeneic hematopoietic stem cell transplantationJunko Takeshita, Shun-Ichi Kimura, Hideki Nakasone, et al.
Blood Advances|February 2, 2022
Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donorsMasaharu Tamaki, Kazuaki Kameda, Shun-Ichi Kimura, et al.
Leukemia & Lymphoma|April 7, 2022
Risk factors and outcomes of definite or clinical idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantationMasaharu Tamaki, Hideki Nakasone, Yuhei Nakamura, et al.
Haematologica|June 20, 2024
Decision analysis for transplant candidates with primary myelofibrosis in the ruxolitinib eraYosuke Okada, Hideki Nakasone, Shunto Kawamura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2013
Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: an analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell TransplantationMakoto Murata, Hideki Nakasone, Junya Kanda, et al.
Pageof 23